These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22384240)

  • 21. Treatment with sitagliptin or metformin does not increase body weight despite predicted reductions in urinary glucose excretion.
    Waters SB; Topp BG; Siler SQ; Alexander CM
    J Diabetes Sci Technol; 2009 Jan; 3(1):68-82. PubMed ID: 20046651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence, persistence, and treatment discontinuation with sitagliptin compared with sulfonylureas as add-ons to metformin: A retrospective cohort database study.
    Bloomgarden ZT; Tunceli K; Liu J; Brodovicz KG; Mavros P; Engel SS; Radican L; Chen Y; Rajpathak S; Qiu Y; Brudi P; Fonseca V
    J Diabetes; 2017 Jul; 9(7):677-688. PubMed ID: 27531167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of sitagliptin on the working memory and reference memory in type 2 diabetic Sprague-Dawley rats: possible role of adiponectin receptors 1.
    Sakr HF
    J Physiol Pharmacol; 2013 Oct; 64(5):613-23. PubMed ID: 24304575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of body weight on antidiabetic treatment and predictors of weight control under real-world conditions: a 2-year follow-up of DiaRegis cohort.
    Hartmann B; Bramlage P; Schneider S; Tschöpe D; Gitt AK
    Acta Diabetol; 2015 Dec; 52(6):1093-101. PubMed ID: 26239142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Metformin Treatment with Respect to Weight Reduction in Children and Adults with Obesity: A Systematic Review.
    Lentferink YE; Knibbe CAJ; van der Vorst MMJ
    Drugs; 2018 Dec; 78(18):1887-1901. PubMed ID: 30511324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
    Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.
    Mu J; Woods J; Zhou YP; Roy RS; Li Z; Zycband E; Feng Y; Zhu L; Li C; Howard AD; Moller DE; Thornberry NA; Zhang BB
    Diabetes; 2006 Jun; 55(6):1695-704. PubMed ID: 16731832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary albumin excretion with sitagliptin compared to sulfonylurea as add on to metformin in type 2 diabetes patients with albuminuria: A real-world evidence study.
    Goldshtein I; Karasik A; Melzer-Cohen C; Engel SS; Yu S; Sharon O; Brodovicz K; Gadir N; Katzeff HL; Radican L; Chodick G; Shalev V; Tunceli K
    J Diabetes Complications; 2016; 30(7):1354-9. PubMed ID: 27320183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of sibutramine in the treatment of obese Type 2 diabetic patients receiving sulphonylurea therapy.
    Serrano-Rios M; Melchionda N; Moreno-Carretero E;
    Diabet Med; 2002 Feb; 19(2):119-24. PubMed ID: 11874427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial.
    Al Sifri S; Basiounny A; Echtay A; Al Omari M; Harman-Boehm I; Kaddaha G; Al Tayeb K; Mahfouz AS; Al Elq A; Radican L; Ozesen C; Katzeff HL; Musser BJ; Suryawanshi S; Girman CJ; Davies MJ; Engel SS;
    Int J Clin Pract; 2011 Nov; 65(11):1132-40. PubMed ID: 21951832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy and tolerability of sitagliptin in type 2 diabetic patients inadequately controlled with metformin. A prospective observational study in austrian primary care].
    Ludvik B; Daniela L
    Wien Klin Wochenschr; 2011 Apr; 123(7-8):235-40. PubMed ID: 21451952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative evaluation of the therapeutic effect of metformin monotherapy with metformin and acupuncture combined therapy on weight loss and insulin sensitivity in diabetic patients.
    Firouzjaei A; Li GC; Wang N; Liu WX; Zhu BM
    Nutr Diabetes; 2016 May; 6(5):e209. PubMed ID: 27136447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Class 3 Obesity in a Multidisciplinary Metabolic Weight Management Program: The Effect of Preexisting Type 2 Diabetes on 6-Month Weight Loss.
    Medveczky DM; Kodsi R; Skelsey K; Grudzinskas K; Bueno F; Ho V; Kormas N; Piya MK
    J Diabetes Res; 2020; 2020():9327910. PubMed ID: 32832564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intentional weight loss and dose reductions of antihypertensive medications: a retrospective cohort study.
    Shantha GPS; Kumar AA; Kahan S; Cheah SY; Cheskin LJ
    Cardiorenal Med; 2013 Apr; 3(1):17-25. PubMed ID: 23946722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variations in inflammatory biomarkers following the addition of sitagliptin in patients with type 2 diabetes not controlled with metformin.
    Derosa G; Carbone A; D'Angelo A; Querci F; Fogari E; Cicero AF; Maffioli P
    Intern Med; 2013; 52(19):2179-87. PubMed ID: 24088749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function.
    Derosa G; Carbone A; D'Angelo A; Querci F; Fogari E; Cicero AF; Maffioli P
    Expert Opin Pharmacother; 2012 Dec; 13(17):2433-42. PubMed ID: 23061989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes.
    Lau DC; Teoh H
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S134-41. PubMed ID: 26654857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sitagliptin: a review of its use in the management of type 2 diabetes mellitus.
    Dhillon S
    Drugs; 2010 Mar; 70(4):489-512. PubMed ID: 20205490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.